• <em>Trypanosoma brucei</em> multi-aminoacyl-tRNA synthetase complex formation limits promiscuous tRNA proofreading
• A man in his sixties with life-threatening febrile illness after travel abroad
• A Nanobody/Monoclonal Antibody "hybrid" sandwich technology offers an improved immunoassay strategy for detection of African trypanosome infections
• A scoping review on tsetse fly blood meal sources and its assay methods since 1956 to 2022
• Adipose and skin distribution of African trypanosomes in natural animal infections
• Advancement in the development of DNA vaccines against Trypanosoma brucei and future perspective
• An <em>In vitro</em> and <em>in silico</em> investigation of the antitrypanosomal activities of the stem bark extracts of <em>Anopyxis klaineana</em> (Pierre) Engl
• Animal models of neglected parasitic diseases: In vivo multimodal imaging of experimental trypanosomatid infections
• Animal trypanosomosis eliminated in a major livestock production region in Senegal following the eradication of a tsetse population
• Anogeissus leiocarpus (DC.) Guill. & Perr. (Combretaceae): A review of the traditional uses, phytochemistry and pharmacology of African birch
• Antiprotozoal Activity of Plants Used in the Management of Sleeping Sickness in Angola and Bioactivity-Guided Fractionation of <em>Brasenia schreberi</em> J.F.Gmel and <em>Nymphaea lotus</em> L. Active against <em>T. b. rhode
• Antitrypanosomal Chloronitrobenzamides
• APOL1-Mediated Kidney Disease
• Ascofuranone antibiotic is a promising trypanocidal drug for nagana
• Beyond the VSG layer: Exploring the role of intrinsic disorder in the invariant surface glycoproteins of African trypanosomes
• Cardiac involvement in Chagas disease and African trypanosomiasis
• Caught in a trap: DNA contamination in tsetse xenomonitoring can lead to over-estimates of Trypanosoma brucei infection
• Comparison of stochastic and deterministic models for gambiense sleeping sickness at different spatial scales: A health area analysis in the DRC
• Comparison of Three Widely Employed Extraction Methods for Metabolomic Analysis of Trypanosoma brucei
• Conducting active screening for human African trypanosomiasis with rapid diagnostic tests: The Guinean experience (2016-2021)
• Consistent detection of Trypanosoma brucei but not T. congolense DNA in faeces of experimentally infected cattle
• Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
• Depolymerization of SUMO chains induces slender to stumpy differentiation in T. brucei bloodstream parasites
• Design, Synthesis, and Evaluation of An Anti-trypanosomal [1,2,4]Triazolo[1,5-a]pyrimidine Probe for Photoaffinity Labeling Studies
• Designing Antitrypanosomal and Antileishmanial BODIPY Derivatives: A Computational and In Vitro Assessment
• Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria
• Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents
• Discovery of Strong 3-Nitro-2-Phenyl-<em>2H</em>-Chromene Analogues as Antitrypanosomal Agents and Inhibitors of <em>Trypanosoma cruzi</em> Glucokinase
• Distinct structural motifs are necessary for targeting and import of Tim17 in <em>Trypanosoma brucei</em> mitochondrion
• Diversity of Glossinidae (Diptera) species in The Gambia in relation to vegetation
• Eflornithine for treatment of high-risk neuroblastoma
• Elimination of human African trypanosomiasis: The long last mile
• Epidemiological study on cattle trypanosomiasis and its vectors distributions in the Gambella regional state, southwestern Ethiopia
• Evaluating for correlations between metabolites in patients receiving immunotherapy for metastatic or recurrent NSCLC: an exploratory study based on two cohorts
• Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts
• Evaluation of ITS1 rDNA primers for the detection and identification of African trypanosomes in mammalian hosts and tsetse flies
• Evaluation of the International Task Force for Disease Eradication: A Review of Past Deliberations
• Experimental genetic crosses in tsetse flies of the livestock pathogen Trypanosoma congolense savannah
• First comprehensive untargeted metabolomics study of suramin-treated Trypanosoma brucei: an integrated data analysis workflow from multifactor data modelling to functional analysis
• From pole to pole, life-long research of sleep in extreme environments
• Generation of a bloodstream form Trypanosoma brucei double glycosyltransferase null mutant competent in receptor-mediated endocytosis of transferrin
• Genetic Diversity of Trypanosomes Infesting Cattle from Savannah District in North of Côte d'Ivoire Using Conserved Genomic Signatures: rRNA, ITS1 and gGAPDH
• Ginkgo biloba attenuated detrimental inflammatory and oxidative events due to Trypanosoma brucei rhodesiense in mice treated with melarsoprol
• Guidelines for the treatment of human African trypanosomiasis
• Haptoglobin is dispensable for haemoglobin uptake by <em>Trypanosoma brucei</em>
• How are Trypanosoma brucei receptors protected from host antibody-mediated attack?
• Human African Trypanosomiasis (Sleeping Sickness)-Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention
• Identification of transport systems involved in eflornithine delivery across the blood-brain barrier
• Imaging Assays to Detect DNA Damage in Trypanosome Parasites Using γH2A
• Improved serodiagnosis of Trypanosoma vivax infections in cattle reveals high infection rates in the livestock regions of Argentina
• In vitro and in vivo antitrypanosomal activity of the fresh leaves of Ranunculus Multifidus Forsk and its major compound anemonin against Trypanosoma congolense field isolate
• In vitro antitrypanosomal activity of synthesized nitrofurantoin-triazole hybrids against Trypanosoma species causing animal African trypanosomosis
• Insights to Design New Drugs against Human African Trypanosomiasis Targeting Rhodesain using Covalent Docking, Molecular Dynamics Simulations, and MM-PBSA Calculations
• Integrated proteomic and metabolomic profiling reveals novel insights on the inflammation and immune response in HFpEF
• Kagimminols A and B, Cembrene-Type Diterpenes from an <em>Okeania</em> sp. Marine Cyanobacterium
• Knowledge, attitudes and practices towards yaws in endemic areas of Ghana, Cameroon and Côte d'Ivoire
• Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy
• Limited impact of vector control on the population genetic structure of Glossina fuscipes fuscipes from the sleeping sickness focus of Maro, Chad
• Lipid Metabolism in Insect Vectors of Diseases
• Modelled impact of Tiny Targets on the distribution and abundance of riverine tsetse
• Modelling timelines to elimination of sleeping sickness in the Democratic Republic of Congo, accounting for possible cryptic human and animal transmission
• Multifunctional Organometallic Compounds Active against Infective Trypanosomes: Ru(II) Ferrocenyl Derivatives with Two Different Bioactive Ligands
• Novel 4-[4-(4-methylpiperazin-1-yl)phenyl]-6-arylpyrimidine derivatives and their antitrypanosomal activities against T.brucei
• Novel aroyl guanidine anti-trypanosomal compounds that exert opposing effects on parasite energy metabolism
• Pass the boron: benzoxaboroles as antiparasite drugs
• Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of <em>Trypanosoma brucei</em>
• Polyamine Metabolism for Drug Intervention in Trypanosomatids
• Prevalence of dermal trypanosomes in suspected and confirmed cases of gambiense human African trypanosomiasis in Guinea
• Privileged small molecules against neglected tropical diseases: A perspective from structure activity relationships
• Prophylactic activity of orally administered dry-heat-sterilized Acremonium egyptiacum against Trypanosoma congolense-induced animal African trypanosomosis
• Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
• Reproductive, productive and financial consequences of chronic Trypanosoma vivax infection in a dairy cattle herd in a region without a cyclic vector
• Selenosugars targeting the infective stage of Trypanosoma brucei with high selectivity
• Specificity of serological screening tests and reference laboratory tests to diagnose gambiense human African trypanosomiasis: a prospective clinical performance study
• State-of-the-art clinical update on African trypanosomiasis
• Study on the underlying molecular mechanism of benzene-induced nervous system damage in mice based on tandem mass tag (TMT) proteomics
• Suramin: Effectiveness of analogues reveals structural features that are important for the potent trypanocidal activity of the drug
• Synthesis and biological evaluation of orally active anti-Trypanosoma agents
• Targeting Trypanothione Metabolism in Trypanosomatids
• The activities of suaveolol and other compounds from Hyptis suaveolens and Momordica charantia against the aetiological agents of African trypanosomiasis, leishmaniasis and malaria
• The comprehensive epidemiological status of human African trypanosomiasis in Nigeria: meta-analysis and systematic review of the full story (1962-2022)
• The current status of neglected tropical diseases in Japan: A scoping review
• The elimination of human African trypanosomiasis: Monitoring progress towards the 2021-2030 WHO road map targets
• The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis
• The internal transcribed spacer 1 sequence polymorphism brings updates to tsetse species distribution in the northern Cameroon: Importance in planning efficient vector control
• The role of tryptophan derivatives as anti-kinetoplastid agents
• The Transmission of Animal African Trypanosomiasis in Two Districts in the Forest Zone of Ghana
• To Explore Potential Inhibitors Against Various Enzymatic Targets of Human African Trypanosomiasis
• Toll-like receptor 9 signaling is associated with immune responses to Trypanosoma brucei infection
• Tractable Quinolone Hydrazides Exhibiting Sub-Micromolar and Broad Spectrum Antitrypanosomal Activities
• Transcriptome profiles of Trypanosoma brucei rhodesiense in Malawi reveal focus specific gene expression profiles associated with pathology
• Trypanocide usage in the cattle belt of southwestern Uganda
• Trypanosoma brucei gambiense group 2 experimental in vivo life cycle: from procyclic to bloodstream form
• Trypanosoma vivax in and outside cattle blood: Parasitological, molecular, and serological detection, reservoir tissues, histopathological lesions, and vertical transmission evaluation
• Unexpected discovery of Trypanosoma brucei gambiense on CSF in a western country: About a case
• Unique Interactions of the Small Translocases of the Mitochondrial Inner Membrane (Tims) in <em>Trypanosoma brucei</em>
• Updating the northern tsetse distribution limit in Chad in the context of global change
• Using Passive Surveillance to Maintain Elimination as a Public Health Problem for Neglected Tropical Diseases: A Model-Based Exploration
• Virulence and pathogenicity of three <em>Trypanosoma brucei rhodesiense</em> stabilates in a Swiss white mouse model
• What is needed to achieve effective and sustainable control of African animal trypanosomosis?